Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yaoshan Qingwen Jiedu granules is a traditional Yao ethnic medicine formulation developed by Beijing Yao Medicine Hospital for the treatment of COVID-19. It is typically used in combination with Yaoshan Qingwen oral spray. The granules are intended to promote virologic clearance (negative nucleic acid conversion) in patients with asymptomatic or mild COVID-19. As a traditional herbal medicine, its mechanism likely involves multi-target effects including anti-inflammatory, immunomodulatory, and potentially direct antiviral activities characteristic of "heat-clearing and detoxifying" (Qingwen Jiedu) TCM/ethnic medicine principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yaoshan Qingwen Jiedu granules.